Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2005 Jul;60(3):256-60.
doi: 10.1016/j.jhin.2005.01.007.

Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002

M Paul  1 , M Weinberger, Y Siegman-Igra, T Lazarovitch, I Ostfeld, I Boldur, Z Samra, H Shula, Y Carmeli, B Rubinovitch, S Pitlik
Affiliations
Multicenter Study

Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002

M Paul et al. J Hosp Infect. 2005 Jul.

Abstract

The incidence of multi-drug-resistant Acinetobacter baumannii bloodstream infections (BSIs) increased two- to four-fold in three Israeli hospitals between 1997 and 2002, accounting for 3.5-18% of all hospital-acquired BSIs. This was associated with increasing carbapenem resistance reaching 35-54%, and by a dramatic increase in carbapenem consumption. In-hospital fatality rates ranged between 47% and 58% and were significantly higher than those seen with other nosocomial Gram-negative pathogens. A. baumannii was not restricted to intensive care units, but had spread to all hospital wards. Multi-drug-resistant A. baumannii has the potential to reach endemicity in hospitals and warrants more vigorous and innovative efforts to limit its spread.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence of Acinetobacter baumannii nosocomial bloodstream infections. Solid line, number of patient-unique episodes per 10 000 patient-days in hospitals A–C; dashed line, carbapenem (imipenem and meropenem) consumption in DDD per 100 patient-days in hospitals A–C.
See this image and copyright information in PMC

References

    1. Bergogne-Berezin E., Towner K.J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148–165. - PMC - PubMed
    1. van Dessel H., Dijkshoorn L., van der Reijden T. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol. 2004;155:105–112. - PubMed
    1. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317. - PubMed
    1. Gales A.C., Jones R.N., Forward K.R., Linares J., Sader H.S., Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997–1999) Clin Infect Dis. 2001;32(Suppl. 2):S104–S113. - PubMed
    1. Velasco E., Byington R., Martins C.S., Schirmer M., Dias L.C., Goncalves V.M. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect. 2004;10:542–549. - PubMed

Publication types

MeSH terms

LinkOut - more resources